Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!

@article{Gordon2010MarkedVO,
  title={Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!},
  author={Ram Y Gordon and Tod Cooperman and William Obermeyer and David J. Becker},
  journal={Archives of internal medicine},
  year={2010},
  volume={170 19},
  pages={1722-7}
}
BACKGROUND Red yeast rice (RYR) is a widely available dietary supplement used by millions of patients as an alternative therapy for hyperlipidemia. It contains 14 active compounds called monacolins that inhibit hepatic cholesterol synthesis. Although studies have suggested that some formulations of RYR may be effective and safe for lipid lowering, monacolin levels are not standardized among marketed products and are generally not published on labels. We evaluated monacolin levels in 12… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 46 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 41 references

Red yeast rice research triggers (mostly) positive news for supplements

  • C. Mast
  • http://blog.nutritionbusinessjournal.com/nbj/2009…
  • 2009
1 Excerpt

The Cholestin case: drugs vs. supplements

  • P. Kimpel
  • http://iml.jou.ufl.edu /projects/Spring2000…
  • 2009
2 Excerpts

Nutrition industry overview

  • C. Mast
  • Nutrition Business J. 2008;13(6/7):3
  • 2008
1 Excerpt

Similar Papers

Loading similar papers…